Monique K. Mansoura, PhD, MBA

Monique K. Mansoura is a Strategic Advisor on critical issues at the intersection of biotechnology and national/economic/health security. She brings technical, policy and business expertise from both public and private sectors. Her focus is on U.S. competitiveness and sustainability of the biotechnology industrial base that is vital to security and the bioeconomy.

From 2002-2011, she led strategic policy, planning and budgeting for a pioneering multibillion-dollar medical countermeasures development and acquisition program in the U.S. Department of Health and Human Services under the authorities of the Project BioShield Act of 2004 and the Pandemic and All-Hazards Preparedness Act of 2006.

From 2012-2016, she was the leader of a Global Program Team at Novartis Vaccines (Seqirus, A CSL Company, after the July 2015 acquisition) including a role as Head, Medical Countermeasures and Government Affairs. Americas. From 2017-2025 she was the Executive Director for Global Health Security and Biotechnology at The MITRE Corporation.

During a recent sabbatical, Monique examined innovative financing approaches in healthcare as a Research Affiliate of the MIT Laboratory for Financial Engineering (LFE), Sloan School of Management. She led an LFE healthcare finance initiative with Professor Andrew Lo that explored new business models and financial vehicles for raising and deploying funds to enhance global health security.

She is a co-author of “Lessons from the COVID War: An Investigative Report”

She earned a PhD in Bioengineering and M.S. in Human Genetics from the University of Michigan, a B.S. in Chemical Engineering from Wayne State University, and completed an NIH post-doctoral fellowship. She earned an MBA in the MIT Sloan Fellows Program in Innovation and Global Leadership.

She is a member of the Council on Foreign Relations.